Helixgate https://validator.w3.org/feed/docs/rss2.html Takeda continues to prune partnerships, cuts ties with mRNA-targeting Veritas In Silico Home RFK Jr. defends FDA, Makary following Republican questions Intercellular Communication via Condensate Corona-Nanoparticle Complexes STAT+: Kennedy focuses on affordability, combating fraud in Capitol Hill hearing Proteins.1 Launches to Develop Single Molecule Protein Amplification Tech for Diagnostics Drug pricing watchdog calls for increased transparency into FDA’s accelerated approval decisions AACR 2026 Chairs Identify Themes and Highlights from the Conference FDA mulls compounding for peptides previously flagged over safety risks STAT+: Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target Cochrane review dismissing amyloid drugs draws immediate backlash Lilly’s new obesity pill passes heart safety test in diabetes MeiraGTx buys back gene therapy from J&J; Storm brings in $56M Series C Landmark Pancreatic Cancer Trial Highlights Promise of RAS-Targeting Daraxonrasib Blurring the lines of healthcare AI MeiraGTx, spying hope in a failed trial, buys back eye disease gene therapy from J&J Using versus selling lucrative PRVs: Moderna’s cautionary tale MSF says Gilead’s lenacapavir supply ‘not nearly enough’; PolyPeptide’s strategic review Lilly’s Foundayo posts ‘outstanding’ diabetes data, possibly easing FDA safety concerns Can Europe turn world-class science into world-class scale? Obesity’s explosive growth continues as Q1 deals exceed total 2025 value STAT+: Pharmalittle: We’re reading about a review of Alzheimer’s drugs, FDA interest in compounded peptides, and more Revolution doubles stock offering target to $2B following pancreatic cancer win Novartis CEO joins Anthropic board, embedding AI in the heart of biopharma The mental health parity gap is gaping Lilly’s obesity pill heads for diabetes filing after heart risk trial STAT+: Roche to launch another Elevidys trial, with eyes on European approval In vivo CAR-T race for autoimmune grows as two RNA startups enter the clinic STAT+: 7 key issues we’re watching as RFK Jr. faces a Congressional gauntlet Pregnancy Sickness Study Identifies New Genetic Links FDA weighs support for compounding popular peptides Biotech stocks are on a tear again STAT+: CMS proposes rolling back breakthrough device payment flexibilities Fujifilm Biotechnologies Opens New QC Lab in Denmark Beeline, a Bain-backed biotech, debuts with immune drugs from Bristol Myers Digital Twin Process Could Slash Microbial Protein Costs Biogen filing reveals Apellis deal details; Telix raises $600M Opinion: STAT+: The medical AI revolution requires rethinking health care’s architecture Scribing startup Abridge adds NEJM, JAMA as it moves into medical AI search Novel Targets for Complex Cancer Revealed by Genetic Regulatory Node Mapping Tampa General’s AI journey Research collaboration to ‘strengthen pandemic preparedness’  Revolution Medicines prices $2B raise as XBI reaches heights not seen since pandemic Astellas’ consolidation efforts to impact 50 Universal Cells employees STAT+: Novartis CEO joins Anthropic’s board Whitepaper: CDMOs at a Crossroads China dominates big licensing deals as M&A starts 2026 with a bang Trump DOJ report says Biden administration treated anti-abortion protestors unfairly Freya Biosciences advances microbial treatment for IVF implantation failure Biopharmas pull back on layoffs in Q1